During the past decade, Seattle Vaccine and Prevention CRS conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Vaccine and Prevention CRS" #1 collaborator was "HIV Vaccine Trials Network" with 7 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "CHAVI" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Dynavax Technologies Corporation" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Seattle Vaccine and Prevention CRS" are "HIV Infections" (23 trials), "COVID-19" (2 trials), "Healthy" (2 trials), "SARS-CoV-2" (2 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Seattle Vaccine and Prevention CRS" in a lesser frequency.

Most popular intervention types in "Seattle Vaccine and Prevention CRS" are "Biological" (25 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ad26.Mos4.HIV" (2 trials), "DNA-HIV-PT123 vaccine" (2 trials), "MVA/HIV62 vaccine" (2 trials) and "Sample collection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Vaccine and Prevention CRS" are 26 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Seattle Vaccine and Prevention CRS". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Seattle Vaccine and Prevention CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Vaccine and Prevention CRS, 20 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".